When the revised EU Annex 1 on sterile medicinal products came into effect, many in the oral solid dose (OSD) world assumed it did not...

In recent years, the cosmetics industry has been under growing scrutiny from regulators, consumers, and even investors. While cosmetics...

Even when drug substance processes are classified as “low bioburden,” aseptic process simulations (APS) are not  optional, especially...